Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Thymus Hyperplasia MeSH Descriptor Data 2025


MeSH Heading
Thymus Hyperplasia
Tree Number(s)
C15.604.816
Unique ID
D013952
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D013952
Scope Note
Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486)
Entry Term(s)
Hyperplasia of Thymus Gland
Thymic Hyperplasia
NLM Classification #
WK 400
See Also
Myasthenia Gravis
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2010/06/25
Thymus Hyperplasia Preferred
page delivered in 0.135s